
### [MONDO:0018266](http://purl.obolibrary.org/obo/MONDO_0018266)
**Label:** ataxia-telangiectasia variant

**Subclasses:** [MONDO:0008840](http://purl.obolibrary.org/obo/MONDO_0008840) (ataxia telangiectasia), 

**Corr. equiv. classes:** [OMIM:208910](http://purl.obolibrary.org/obo/OMIM_208910), [Orphanet:100](http://www.orpha.net/ORDO/Orphanet_100), [OMIM:208900](http://purl.obolibrary.org/obo/OMIM_208900), 

**Class expressions from DL-Learner:**

- [HP:0012539](http://purl.obolibrary.org/obo/HP_0012539) (Non-Hodgkin lymphoma) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 66.67%
- [HP:0012539](http://purl.obolibrary.org/obo/HP_0012539) (Non-Hodgkin lymphoma) and [HP:0100579](http://purl.obolibrary.org/obo/HP_0100579) (Mucosal telangiectasiae) 66.67%
- [HP:0012539](http://purl.obolibrary.org/obo/HP_0012539) (Non-Hodgkin lymphoma) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 66.67%
- [HP:0012539](http://purl.obolibrary.org/obo/HP_0012539) (Non-Hodgkin lymphoma) and [HP:0045056](http://purl.obolibrary.org/obo/HP_0045056) (Abnormal levels of alpha-fetoprotein) 66.67%
- [HP:0012539](http://purl.obolibrary.org/obo/HP_0012539) (Non-Hodgkin lymphoma) and [HP:0031066](http://purl.obolibrary.org/obo/HP_0031066) (Abnormal ovarian physiology) 66.67%
- [HP:0012539](http://purl.obolibrary.org/obo/HP_0012539) (Non-Hodgkin lymphoma) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) 66.67%
- [HP:0012539](http://purl.obolibrary.org/obo/HP_0012539) (Non-Hodgkin lymphoma) and [HP:0025426](http://purl.obolibrary.org/obo/HP_0025426) (Abnormal bronchus morphology) 66.67%
- [HP:0012539](http://purl.obolibrary.org/obo/HP_0012539) (Non-Hodgkin lymphoma) and [HP:0012874](http://purl.obolibrary.org/obo/HP_0012874) (Abnormal male reproductive system physiology) 66.67%
- [HP:0012539](http://purl.obolibrary.org/obo/HP_0012539) (Non-Hodgkin lymphoma) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 66.67%
- [HP:0012539](http://purl.obolibrary.org/obo/HP_0012539) (Non-Hodgkin lymphoma) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 66.67%
- [HP:0012539](http://purl.obolibrary.org/obo/HP_0012539) (Non-Hodgkin lymphoma) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 66.67%
- [HP:0012539](http://purl.obolibrary.org/obo/HP_0012539) (Non-Hodgkin lymphoma) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 66.67%
- [HP:0012539](http://purl.obolibrary.org/obo/HP_0012539) (Non-Hodgkin lymphoma) and [HP:0012547](http://purl.obolibrary.org/obo/HP_0012547) (Abnormal involuntary eye movements) 66.67%
- [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) and [HP:0012539](http://purl.obolibrary.org/obo/HP_0012539) (Non-Hodgkin lymphoma) 66.67%
- [HP:0012387](http://purl.obolibrary.org/obo/HP_0012387) (Bronchitis) and [HP:0012539](http://purl.obolibrary.org/obo/HP_0012539) (Non-Hodgkin lymphoma) 66.67%


